SCHEMBL21173162

SCHEMBL21173162

CCOC(=O)c1ccc2c(c1)CC(C)[C@H](F)N2C(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.43
SRD5A2 P31213 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 5/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
MAPK1 P28482 1/20 0.41
TP53 P04637 1/20 0.40
MAPT P10636 2/20 0.40
PRMT1 Q99873 1/20 0.40
HTR7 P34969 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
WDR5 P61964 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21172502 0.88 SRD5A1 (0.45) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL24347596 0.88 SRD5A1 (0.45) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL24347185 0.87 SRD5A1 (0.44) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21172626 0.86 SRD5A1 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL24347614 0.86 SRD5A1 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21172631 0.84 TP53 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21172578 0.84 TP53 (0.43) SRD5A1SRD5A2SMN1; SMN2ALDH1A1CA12
SCHEMBL21173212 0.83 TDP1 (0.43) ALDH1A1MAPTL3MBTL1KDM4EHPGD
SCHEMBL21172814 0.83 TDP1 (0.43) ALDH1A1MAPTL3MBTL1KDM4EHPGD
SCHEMBL21172659 0.82 KDM4E (0.43) ALDH1A1MAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511323-A1 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS GlaxoSmithKline Intellectual Property (No.2) Limited (GB) 2019-07-17 EP disclosed